Physician profile
Casey B Duncan
NPI 1962669978
$1,261.38
in general payments reported to CMS, 2019-2025
18 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $238 · 2022: $26.34 · 2023: $279 · 2024: $234 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.98 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $320.95 | 2023-2024 | Spy-Phi System, Molli |
| Kci USA, INC. | $138.05 | 2019-2020 | |
| Ethicon US, LLC | $134.98 | 2019-2023 | Prolene |
| Elucent Medical | $119.70 | 2025 | |
| Abbott Laboratories | $93.25 | 2024 | Freestyle Libre 3 |
| Acell, INC. | $85.09 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Covidien LP | $54.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.05 | 2019-2022 | |
| Tetraphase Pharmaceuticals, INC. | $39.65 | 2019 | |
| Smith+Nephew, INC. | $30.98 | 2023-2024 | Stravix, Oasis, Grafix |
| Convatec INC. | $23.22 | 2020 | |
| Allergan, INC. | $21.48 | 2019 | |
| Organon LLC | $19.42 | 2023 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $19.20 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.70 | 2019 | |
| Kerecis Limited | $14.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Angiodynamics, INC. | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.